Database Locked for the Women’s Health Study
The database for the Phase III Women’s Health Study was locked on February 4th after 7 years of trial duration.
This is a multi-center, randomized, double-blind study conducted in patients with a previous preterm delivery, for its further prevention..
February 8, 2019
Phase-III Ophthalmic Study is Approved within 44 Working Days
The end of the year was marked for GCT team with yet another achievement.
Clinical trial approval was received ahead of official timelines for Phase III study,
– the whole review process, including Q/A with competent authority, lasted 44 working days.
January 10, 2019
End of enrollment for Phase II Ulcerative Colitis trial
Enrollment has just been accomplished for a study in patients with moderate to severe Ulcerative Colitis,
a global double-blind, placebo-controlled, parallel group multicenter study designed to evaluate the
safety profile of the investigational product.
December 27, 2018
2018 has come to the end, and we are glad to look back to what was achieved and to share GCT year in the Highlights!
We would like to thank our long-term partners for the credibility, trust and loyalty, and we hope for the new accomplishments together in the coming year!
December 25, 2018
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.
Washington, DC, USA
2019, February 19-21
Centro de Congressos de Lisboa
2019, March 26-31
2019, April 6-9
Tel Aviv, Israel
2019, May 14-16